Mereo Biopharma Group PLC
NASDAQ:MREO
Mereo Biopharma Group PLC
Operating Expenses
Mereo Biopharma Group PLC
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mereo Biopharma Group PLC
NASDAQ:MREO
|
Operating Expenses
-£44.5m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Operating Expenses
-$178.1m
|
CAGR 3-Years
-157%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Operating Expenses
-$177.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Operating Expenses
-$221.5m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Operating Expenses
-£308m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Operating Expenses
-£620.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
See Also
What is Mereo Biopharma Group PLC's Operating Expenses?
Operating Expenses
-44.5m
GBP
Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's Operating Expenses amounts to -44.5m GBP.
What is Mereo Biopharma Group PLC's Operating Expenses growth rate?
Operating Expenses CAGR 3Y
-4%
Over the last year, the Operating Expenses growth was -13%. The average annual Operating Expenses growth rates for Mereo Biopharma Group PLC have been -4% over the past three years .